Dr. David Meya
MBChB, MMed and PhD
Dr. Meya from Makerere University, has been involved in clinical research of central nervous system infections and complications, with a focus on HIV Immune Reconstitution Inflammatory syndrome (IRIS). Dr. Meya has led epidemiological and translational research studies as well as randomized clinical trials In prevention and treatment of Cryptococcus meningitis.
Dr. Meya also has a specific interest in public health interventions to prevent meningitis at population level. He has advocated for cryptococcal antigen (CrAg) screening as a strategy to reduce deaths and hospitalizations from cryptococcal meningitis. Dr. Meya continues to lead the efforts to initiate implementation of the national CrAg screening program in collaboration with the Ministry of Health, Clinton Health Access Initiative (CHAI), the Central public health laboratories and U.S. CDC.